These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 34889296)
1. The effectiveness of cyclosporine A for patients with steroid-resistant nephrotic syndrome: A protocol for systematic review and meta-analysis. Lv J; Luo S; Zhang Y; Dai E Medicine (Baltimore); 2021 Dec; 100(49):e28186. PubMed ID: 34889296 [TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolones increase the risk of aortic aneurysm and dissection: A protocol for meta-analysis. Zhang J; Zhang Z Medicine (Baltimore); 2021 Dec; 100(51):e28081. PubMed ID: 34941048 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of SGLT2 inhibitors in patients with heart failure: A protocol for systematic review and meta-analysis. Wang L; Guo X Medicine (Baltimore); 2022 Jan; 101(3):e28636. PubMed ID: 35060548 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis. Li HY; Zhang X; Zhou T; Zhong Z; Zhong H BMC Nephrol; 2019 Oct; 20(1):384. PubMed ID: 31646979 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of cyclosporine A in treatment of refractory nephrotic syndrome in children: a systematic review of randomized controlled trials]. Chen LZ; Jiang XY; Lu HY; Zhang QL; Mo Y Zhonghua Er Ke Za Zhi; 2009 Dec; 47(12):898-903. PubMed ID: 20193140 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of probiotic preparations on inflammatory cytokines in patients with chronic kidney disease: A protocol for systematic review and meta-analysis. Wang P; Peng Y; Guo Y; Zhao Y Medicine (Baltimore); 2021 Jul; 100(26):e26422. PubMed ID: 34190163 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of levetiracetam in the treatment of pediatric epilepsy: A protocol for systematic review and meta-analysis. Pang Q; Li B; Zhang S; Li J; Gu S Medicine (Baltimore); 2022 Feb; 101(8):e28882. PubMed ID: 35212288 [TBL] [Abstract][Full Text] [Related]
8. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Liu ID; Willis NS; Craig JC; Hodson EM Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142 [TBL] [Abstract][Full Text] [Related]
9. Bevacizumab combined with chemotherapy for ovarian cancer: A protocol for systematic review and meta-analysis. Liao T; Li L; Wang L Medicine (Baltimore); 2021 Dec; 100(51):e28376. PubMed ID: 34941162 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study. Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003 [TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide versus cyclosporine A therapy in steroid-resistant nephrotic syndrome: a retrospective study with a mean 5-year follow-up. Liu Y; Yang R; Yang C; Dong S; Zhu Y; Zhao M; Yuan F; Gui K J Int Med Res; 2018 Nov; 46(11):4506-4517. PubMed ID: 30185089 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of different types of antihypertensive drugs in reversing left ventricular hypertrophy as determined with echocardiography in hypertensive patients: A protocol for systematic review and meta-analysis. Xu H; Hu B; Wu W; Jin Y Medicine (Baltimore); 2021 Jun; 100(25):e26455. PubMed ID: 34160443 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Büscher AK; Kranz B; Büscher R; Hildebrandt F; Dworniczak B; Pennekamp P; Kuwertz-Bröking E; Wingen AM; John U; Kemper M; Monnens L; Hoyer PF; Weber S; Konrad M Clin J Am Soc Nephrol; 2010 Nov; 5(11):2075-84. PubMed ID: 20798252 [TBL] [Abstract][Full Text] [Related]
14. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome. Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S; Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027 [TBL] [Abstract][Full Text] [Related]
15. Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review. Shah SR; Altaf A; Arshad MH; Mari A; Noorani S; Saeed E; Mevawalla AA; Haq ZU; Faquih ME Glob J Health Sci; 2015 Aug; 8(4):136-41. PubMed ID: 26573045 [TBL] [Abstract][Full Text] [Related]
16. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol. Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of aquatic therapy in stroke rehabilitation: A protocol for systematic review and meta-analysis. Li Y; Zheng G Medicine (Baltimore); 2021 Dec; 100(48):e27825. PubMed ID: 35049184 [TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
20. Chinese massage (Tuina) combline with paraffin therapy versus tuina or paraffin therapy alone for the treatment of congenital muscular torticollis: A protocol for systematic review and Bayesian network meta-analysis. Song H; Zhang X; Zou X Medicine (Baltimore); 2021 Nov; 100(44):e27648. PubMed ID: 34871237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]